However, the IPM defined risk had no relationship with sex, smokers or never smokers, T stage, residual tumor, EGFR mutation, ALK mutation, ROS1 mutation, BRAF mutation, and WT/MUT groups (all P > 0.05). Here, ROS1 is linked to neoplasm.